000 01492 a2200433 4500
005 20250514063501.0
264 0 _c20030507
008 200305s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.11273
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFlaherty, Keith T
245 0 0 _aDose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.
_h[electronic resource]
260 _bCancer
_cApr 2003
300 _a1985-90 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aStevenson, James P
700 1 _aGallagher, Maryann
700 1 _aGiantonio, Bruce
700 1 _aAlgazy, Kenneth M
700 1 _aSun, Weijing
700 1 _aHaller, Daniel G
700 1 _aO'Dwyer, Peter J
773 0 _tCancer
_gvol. 97
_gno. 8
_gp. 1985-90
856 4 0 _uhttps://doi.org/10.1002/cncr.11273
_zAvailable from publisher's website
999 _c12466556
_d12466556